Image
|
Figure Caption
Fig. 4 Cell fate specification is unaltered in CaMKII morphants. Representative morphant embryos injected with 3 ng mismatch morpholino oligonucleotide (MO), 3 ng camk2b1 MO or 1.5 ng camk2g1 MO are shown at shield (A–F) and 75% epiboly (G–I) stages with dorsal to the right. (A–C) Animal pole view probed for the dorsal side organizer gsc. (D–I) Lateral view probed for bmp4 expression.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Dev. Dyn.